Letter to the editor: In patients with established NASH cirrhosis, is there no role of weight reduction in reversing fibrosis?
Ashish Kumar, Praveen Sharma, Anil Arora – 28 January 2022
Contrast‐enhanced CT and liver surface nodularity for the diagnosis of porto‐sinusoidal vascular disorder: A case‐control study
Shantha Ram Valainathan, Riccardo Sartoris, Laure Elkrief, Marta Magaz, Fabian Betancourt, Silvia Pellegrino, Arianna Nivolli, Marco Dioguardi Burgio, Yves Flattet, Sylvain Terraz, Nicolas Drilhon, Marie Lazareth, Julia Herrou, Onorina Bruno, Audrey Payance, Aurélie Plessier, François Durand, Maxime Ronot, Dominique‐Charles Valla, Valérie Paradis, Juan Carlos Garcia‐Pagan, Valérie Vilgrain, Pierre‐Emmanuel Rautou – 28 January 2022
Nonalcoholic Fatty Liver Disease: The Role of Visceral Adipose Tissue
Courtney L. Hanlon, Liyun Yuan – 27 January 2022
NASH and the Gut Microbiome: Implications for New Therapies
Cynthia J. Tsay, Joseph K. Lim – 27 January 2022
Identifying the patient with acute‐on‐chronic liver failure: navigating through multiple definitions
Nikki Duong, Jasmohan Singh Bajaj – 27 January 2022
The Patient Perspective on Telemedicine
Karen Hoyt, Andrew Reynolds – 27 January 2022
Surgical Considerations Regarding Transplantation for the Patient With Acute‐on‐Chronic Liver Failure
Sobia Nasir Laique, Bijan Eghtesad, Christina C. Lindenmeyer – 27 January 2022
The Liver Biopsy in Neonatal Cholestasis: Just a Cherry on Top?
Abigail E. Russi, Sindhu Pandurangi, Jorge A. Bezerra – 27 January 2022
No Salvation Without Regeneration
Sergio Duarte – 27 January 2022
Nonalcoholic Fatty Liver Disease: The Role of Visceral Adipose Tissue
Courtney L. Hanlon, Liyun Yuan – 27 January 2022